Frequently Asked Questions
North America is expected to dominate the IVD in cardiology and neurology market due to the strong base of healthcare facilities, the strong presence of major players in the market and the extraordinary healthcare infrastructure.
The latest development in the IVD in cardiology and neurology market is - Thermo Fisher Scientific, a global leader in scientific solutions, unveiled the Applied Biosystems Taq Path Respiratory Viral Select Panel.
Advancements in Diagnostic Technologies & Increasing Prevalence of Cardiovascular and Neurological Disorders are the growth drivers of the IVD in cardiology and neurology market.
Product type, technology, and end user are the factors on which the IVD in cardiology and neurology market research is based.
Major companies in the IVD in cardiology and neurology market are Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Sysmex Corporation (Japan), Siemens Healthineers AG (Germany), Quest Diagnostics Incorporated (U.S.), Abbott (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Beckman Coulter, Inc. (U.S.).
